NorthRock Partners LLC boosted its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 250.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 176,076 shares of the company's stock after purchasing an additional 125,902 shares during the quarter. NorthRock Partners LLC's holdings in Procter & Gamble were worth $27,054,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also bought and sold shares of the company. Czech National Bank lifted its position in Procter & Gamble by 3.8% in the 3rd quarter. Czech National Bank now owns 594,914 shares of the company's stock worth $91,409,000 after buying an additional 21,825 shares during the last quarter. Westerkirk Capital Inc. bought a new position in Procter & Gamble during the second quarter valued at approximately $4,796,000. Vega Investment Solutions raised its stake in shares of Procter & Gamble by 1.3% during the second quarter. Vega Investment Solutions now owns 638,400 shares of the company's stock worth $101,710,000 after acquiring an additional 8,500 shares in the last quarter. Triodos Investment Management BV raised its stake in shares of Procter & Gamble by 7.3% during the third quarter. Triodos Investment Management BV now owns 255,095 shares of the company's stock worth $39,195,000 after acquiring an additional 17,400 shares in the last quarter. Finally, Jump Financial LLC bought a new stake in shares of Procter & Gamble in the 2nd quarter worth approximately $7,891,000. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Trading Up 0.0%
NYSE:PG opened at $150.57 on Friday. The firm has a market capitalization of $349.91 billion, a P/E ratio of 22.31, a P/E/G ratio of 5.03 and a beta of 0.37. The company has a quick ratio of 0.51, a current ratio of 0.72 and a debt-to-equity ratio of 0.49. The company has a fifty day moving average of $153.32 and a 200 day moving average of $151.03. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $174.80.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same quarter last year, the firm earned $1.88 EPS. The company's revenue was up 1.5% on a year-over-year basis. On average, research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were paid a $1.0568 dividend. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble's dividend payout ratio (DPR) is presently 62.52%.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on PG shares. UBS Group increased their target price on shares of Procter & Gamble from $161.00 to $170.00 and gave the company a "buy" rating in a report on Friday, January 23rd. Dbs Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating in a research note on Friday, January 23rd. Barclays set a $155.00 price target on shares of Procter & Gamble in a research report on Friday, January 16th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Procter & Gamble in a research note on Monday, December 29th. Finally, Piper Sandler assumed coverage on Procter & Gamble in a research note on Wednesday, January 7th. They issued a "neutral" rating and a $150.00 target price for the company. Fourteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $168.33.
View Our Latest Research Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, Chairman Jon R. Moeller sold 162,232 shares of the company's stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the transaction, the chairman owned 319,385 shares of the company's stock, valued at $51,884,093.25. This represents a 33.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Marc S. Pritchard sold 95,903 shares of the stock in a transaction that occurred on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total value of $14,495,738.45. Following the completion of the sale, the insider owned 182,607 shares of the company's stock, valued at approximately $27,601,048.05. This trade represents a 34.43% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 348,618 shares of company stock worth $55,462,643 over the last 90 days. 0.20% of the stock is owned by insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report